Variational AI Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 16

Variational AI General Information

Description

Developer of an artificial intelligence-based drug discovery platform designed to accelerate preclinical research and develop novel kinase inhibitors for solid tumors. The company offers a foundation model that designs potent, selective, safe, and synthesizable small molecules, degraders, and payloads for ADCs, enabling biopharmaceutical companies to perform efficient multi-property molecular optimization, identify new therapeutic candidates across diverse targets, and reduce the time required for drug discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1825 Quebec Street
  • Suite 201
  • Vancouver, British Columbia V5T 2Z3
  • Canada
+1 (604)
Primary Industry
Drug Discovery
Corporate Office
  • 1825 Quebec Street
  • Suite 201
  • Vancouver, British Columbia V5T 2Z3
  • Canada
+1 (604)

Variational AI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Variational AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 10-Jul-2025 Completed Generating Revenue
4. Seed Round 17-Jan-2025 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
2. Seed Round 17-Nov-2021 $3.5M $3.71M Completed Generating Revenue
1. Seed Round 17-Jan-2020 $210K $210K Completed Generating Revenue
To view Variational AI’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Variational AI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-based drug discovery platform designed to accelerate preclinical research and de
Drug Discovery
Vancouver, Canada
20 As of 2025

Oxford, United Kingdom
 

San Mateo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Variational AI Competitors (10)

One of Variational AI’s 10 competitors is Exscientia, a Formerly VC-backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exscientia Formerly VC-backed Oxford, United Kingdom
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
Superluminal Medicines Venture Capital-Backed Boston, MA
PostEra Venture Capital-Backed Cambridge, MA
BenevolentAI Formerly PE-Backed Luxembourg, Luxembourg
You’re viewing 5 of 10 competitors. Get the full list »

Variational AI Patents

Variational AI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240228460-A1 Protease inhibitors and methods of making same Pending 21-Dec-2022
WO-2024130411-A1 Protease inhibitors and methods of using same Inactive 21-Dec-2022

Variational AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Variational AI Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life Sciences BC Accelerator/Incubator
Accellius Capital Venture Capital Minority
Angel (individual) Minority
Canada's Digital Technology Supercluster Accelerator/Incubator Minority
Defined Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Variational AI FAQs

  • When was Variational AI founded?

    Variational AI was founded in 2019.

  • Where is Variational AI headquartered?

    Variational AI is headquartered in Vancouver, Canada.

  • What is the size of Variational AI?

    Variational AI has 20 total employees.

  • What industry is Variational AI in?

    Variational AI’s primary industry is Drug Discovery.

  • Is Variational AI a private or public company?

    Variational AI is a Private company.

  • What is Variational AI’s current revenue?

    The current revenue for Variational AI is .

  • How much funding has Variational AI raised over time?

    Variational AI has raised $9.2M.

  • Who are Variational AI’s investors?

    Life Sciences BC, Accellius Capital, , Canada's Digital Technology Supercluster, and Defined are 5 of 16 investors who have invested in Variational AI.

  • Who are Variational AI’s competitors?

    Exscientia, Genesis Molecular AI, Superluminal Medicines, PostEra, and BenevolentAI are some of the 10 competitors of Variational AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process